1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Copland Road Capital Corporation

Copland Road Capital Corporation

CRCC.CN
Copland Road Capital CorporationCA flagCanadian Securities Exchange
0.13
CAD
- -
- -
1.44MMarket Cap
Copland Road Capital Corporation
CRCC.CN
(Canadian Securities Exchange)

Recent

price

0.13

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.47
- -
0.01
0.05
0.15
0.1
0.05
- -
- -
0.01
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.67
0.62
-0.01
- -
0.11
0.04
-0.05
-0.02
-0.21
-0.18
-0.15
1.73
-0.06
-0.01
-0.05
-0.04
-0.04
Basic EPS, GAAP
-0.45
- -
-0.12
- -
0.03
0.03
0.02
- -
-0.06
-0.47
-0.05
-0.35
-0.05
-0.03
-0.03
-0.02
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.33
-0.71
-0.11
-0.04
0.07
0.1
0.06
0.04
-0.09
-0.04
-0.29
0.09
0.1
0.13
0.07
0.03
0.03
Book Value per Share
-1.08
-0.27
0.05
0.05
0.16
0.15
0.1
0.08
0.04
-0.07
-0.33
0.1
0.1
0.13
0.07
0.03
0.03
Tangible Book Value per Share
1
1
3
6
6
11
13
13
24
98
120
12
8
11
11
11
11
Basic Weighted Avg Shares
1
- -
- -
- -
1
1
1
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-118.72
- -
-200.11
0.68
42.59
33.8
7.82
- -
- -
-2,010.6
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
- -
- -
- -
- -
- -
- -
Depreciation Expense
-1
1
- -
- -
1
- -
-1
- -
-5
-17
-18
21
- -
- -
-1
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
22.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-141.24
- -
-153.27
-2.71
71.47
37.48
-94.01
- -
- -
-2,686.79
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-1
- -
- -
- -
1
2
1
1
1
-9
-41
1
1
1
1
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
23
- -
- -
- -
- -
- -
- -
- -
LT Debt
-1
- -
- -
- -
1
2
1
1
1
13
-23
1
1
1
1
- -
- -
Total Equity
- -
- -
- -
- -
- -
22.67
- -
- -
- -
- -
- -
-21.39
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
-96.41
- -
- -
- -
54.67
- -
- -
- -
- -
- -
911.68
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
54.61
-62.31
-48.28
- -
- -
- -
- -
-45.45
-14.39
-54.96
-69.8
-69.8
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
2
2
1

Working Capital

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
95.07%
-33.32%
-51.74%
Free Cash Flow
696.01%
-33.69%
-15.46%
Net Income, GAAP
138.72%
-27.99%
-31.72%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.01
-0.01
-0.01
- -
-0.01
2024
- -
- -
- -
- -
-0.05
2025
-0.01
-0.01
-0.01
- -
-0.04

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Medexus Pharmaceuticals Inc. (MEDXF)
HEXO Corp. (HEXO.TO)
ScinoPharm Taiwan, Ltd. (1789.TW)
Together Pharma Ltd. (TGTR.TA)
Whan In Pharm Co.,Ltd. (016580.KS)
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
Business
Copland Road Capital Corporation (CRCC.CN) is a Canada-based entrepreneurial investment holding company listed on the Canadian Securities Exchange that identifies and invests in equity and debt obligations of growth-minded businesses; provides primary capital, expert advisory services, and access to equity capital markets; and supports portfolio companies through its experienced management team and board of institutional investors, founders, executives, directors, and M&A advisors. The company focuses on sectors including cannabis, real property, and other industries with potential for sustained returns on capital, preferring strategic minority stakes, majority positions in U.S.-targeted investments, and structures where sellers retain significant equity consideration. Founded in 2002 and headquartered at 217 Queen Street West, Suite 401, Toronto, Ontario M5V 0R2, Canada, it operates primarily in Canada and the United States through subsidiaries such as Nabis (US) Corp., Nabis AZ LLC, Nabis Holdings California LLC, Nabis Holdings Oklahoma Inc., Nabis Oklahoma Patient Care Inc., Bothwell Road Capital Corp., Broomloan Road Capital Corp., Edmiston Drive Capital Corp., Goram Capital Corp., and James Bell Capital Corp. In January 2023, Copland Road closed an oversubscribed non-brokered private placement of 2,713,500 common shares at $0.25 for gross proceeds of $678,375 to fund working capital and general corporate purposes; completed a plan of arrangement with its spinco subsidiaries, including a distribution of shares; and in July 2022 incorporated five new subsidiaries for strategic investments. The company appointed Joanna Groszek as Chief Financial Officer in June 2022 and holds its 2025 annual general meeting on October 15, with recent financial reporting for Q3 and nine months ended September 30, 2025.

Company News

APIChatGPT

  • feeds.newsfilecorp.com

    Copland Road Capital Corporation Announces Closing of Non-Brokered Private Placement of Units

  • feeds.newsfilecorp.com

    Copland Road Capital Corporation Announces Non-Brokered Private Placement of Units and Adopts Semi-Annual Financial Reporting